KBC Group NV lowered its stake in shares of Quorum Health Corp (NYSE:QHC) by 15.9% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 78,651 shares of the company’s stock after selling 14,880 shares during the quarter. KBC Group NV owned approximately 0.26% of Quorum Health worth $407,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently bought and sold shares of the stock. California Public Employees Retirement System boosted its position in Quorum Health by 21.9% during the first quarter. California Public Employees Retirement System now owns 111,349 shares of the company’s stock worth $606,000 after purchasing an additional 20,000 shares during the period. Vanguard Group Inc. boosted its position in Quorum Health by 10.3% during the first quarter. Vanguard Group Inc. now owns 1,568,666 shares of the company’s stock worth $8,534,000 after purchasing an additional 145,904 shares during the period. Geode Capital Management LLC boosted its position in Quorum Health by 2.6% during the first quarter. Geode Capital Management LLC now owns 213,177 shares of the company’s stock worth $1,159,000 after purchasing an additional 5,373 shares during the period. Dimensional Fund Advisors LP boosted its position in shares of Quorum Health by 12.9% in the first quarter. Dimensional Fund Advisors LP now owns 1,092,288 shares of the company’s stock valued at $5,942,000 after acquiring an additional 124,723 shares during the period. Finally, Renaissance Technologies LLC bought a new position in shares of Quorum Health in the first quarter valued at approximately $459,000. Institutional investors own 81.83% of the company’s stock.
A number of equities analysts have recently commented on QHC shares. Zacks Investment Research upgraded shares of Quorum Health from a “hold” rating to a “buy” rating and set a $4.75 price objective for the company in a research report on Wednesday, September 13th. Royal Bank of Canada restated a “hold” rating and issued a $5.00 price objective on shares of Quorum Health in a research report on Tuesday, October 3rd. Finally, ValuEngine upgraded shares of Quorum Health from a “strong sell” rating to a “sell” rating in a research report on Friday, September 1st. Four analysts have rated the stock with a sell rating and three have given a hold rating to the company. Quorum Health currently has a consensus rating of “Sell” and an average target price of $4.13.
In related news, SVP Shaheed Koury bought 10,000 shares of the stock in a transaction that occurred on Monday, November 13th. The shares were acquired at an average cost of $4.69 per share, with a total value of $46,900.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 4.70% of the company’s stock.
TRADEMARK VIOLATION WARNING: This piece of content was first published by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this piece of content on another site, it was stolen and reposted in violation of US and international copyright law. The original version of this piece of content can be viewed at https://sportsperspectives.com/2017/12/17/kbc-group-nv-trims-position-in-quorum-health-corp-qhc.html.
Quorum Health Company Profile
Quorum Health Corporation is an operator and manager of general acute care hospitals and outpatient services in the United States. The Company operates in two segments: Hospital operations, which includes its general acute care hospitals and related healthcare entities that provide inpatient and outpatient healthcare services, and hospital management advisory and consulting services, which includes Quorum Health Resources, LLC (QHR).
Want to see what other hedge funds are holding QHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Quorum Health Corp (NYSE:QHC).
Receive News & Ratings for Quorum Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quorum Health and related companies with MarketBeat.com's FREE daily email newsletter.